Name: Latest research reports of Laurus Labs Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Laurus Labs Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

1108.0000 16.10 (1.47%)

NSE Dec 31, 2025 15:31 PM

New 52W High today

Volume: 1.6M

Laurus Labs Ltd.

25 Jan 2024

1108.00

1.47%

Laurus Labs (SELL): Challenges galore cut to SELL

Sell: Laurus Labs Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Fourth straight quarterly miss with upsets on all fronts; Q3 revenue/ EBITDA well short of Bloomberg consensus by 13%/79%

Number of FII/FPI investors increased from 293 to 340 in Sep 2025 qtr.